DrAnsay
DrAnsay is a German-focused telemedicine platform connecting patients with licensed physicians for online prescriptions in medical cannabis, weight loss, men's and women's health, and general medicine, supported by a 350+ partner pharmacy marketplace with 1,400+ products.
- Company typePrivate
- Founded2018
- HeadquartersValletta, Malta
- Headcount11–50
- GTM typeB2C
- OfferingServices
What DrAnsay does
DrAnsay operates a German-focused telemedicine platform, legally domiciled as Dr. Ansay Ltd. in Valletta, Malta, that connects patients with licensed physicians for online consultations and prescriptions. The company's core service is the online issuance of medical cannabis prescriptions, supported by an integrated marketplace aggregating 350+ certified German pharmacies offering 1,400+ cannabis products (flowers, extracts, inhalations, drinkables, edibles, capsules) with price comparison and a best-price guarantee. It has expanded into adjacent prescription categories including GLP-1 weight-loss medications, men's health (erectile dysfunction, hair loss), women's health (PMS, endometriosis), and general medicine (digital sick notes). The platform claims more than 1 million patients served and 3 million treatments processed, with prescription turnaround of 5–90 minutes and delivery within 1–4 business days.
The technology stack combines an asynchronous digital medical questionnaire reviewed by physicians, an optional video consultation channel, a 24/7 AI chatbot (DrAnsAI) for text-based health queries, and a pharmacy price-comparison marketplace with best-price guarantee. Supporting infrastructure includes dedicated iOS and Android applications, WhatsApp-based advisory, integrations with PayPal, Visa, Mastercard, American Express, Klarna, and Apple Pay, and shipping through DHL, DHL Express, GLS, Hermes, FedEx, and GO!. The platform is registered in Germany's Versandhandels-Register and operates under GDPR/DSGVO data protection standards.
DrAnsay generates revenue through per-consultation fees, commissions on pharmacy marketplace transactions, and direct margin on cannabis product sales. Pricing is unit-based: cannabis prescription consultations start at €14.20, and cannabis flowers range from €2.99/g to €9.43/g depending on strain and THC content. Go-to-market is product-led via a self-serve digital funnel, combined with content marketing, influencer and celebrity endorsements (Tanja Bülter, Sonya Kraus, Bruce Darnell, CAPO), earned media in major German publications, and SEO. The company is privately held and founder-controlled under Managing Director Dr. Can Ansay, with no disclosed external institutional investors or funding rounds.
DrAnsay firmographics
Firmographics- Name
- DrAnsay
- Legal name
- Dr. Ansay Ltd.
- Website
- https://dransay.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DrAnsay is a German-focused telemedicine platform connecting patients with licensed physicians for online prescriptions in medical cannabis, weight loss, men's and women's health, and general medicine, supported by a 350+ partner pharmacy marketplace with 1,400+ products.
- Ownership category
- akta.pro rank
DrAnsay industry classification
Industry- Product category
- Telemedicine / Online Healthcare Services
- NAICS
- Offices of Physicians (62111), Offices of Physicians (6211), Pharmacies and Drug Retailers (45611)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Prepackaged Software (7372)
- akta.pro primary industry
- DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)
- akta.pro secondary industries
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI), Telepharmacy & Prescription Fulfillment Marketplaces (HLALALAF), Men’s Health Prescribing + Pharmacy Delivery Platforms (HLALAIAJ)
Keywords
Where DrAnsay is headquartered
LocationHeadquarters
- HQ city
- Valletta
- HQ country
- Malta
- HQ region
- Europe
Offices1 record
Markets served
DrAnsay business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Consultation Fees: Patients pay consultation fees for online medical evaluations and prescription issuance. The service includes optional video consultation with physicians.
- Pharmacy Marketplace Commission: Platform facilitates transactions between patients and partner pharmacies, earning commissions on medication sales including medical cannabis flowers (from €2.99/g), extracts, and other prescription products.
- Cannabis Product Sales: Direct sales of medical cannabis products through the integrated shop, with pricing from partner pharmacies including margins on flowers, extracts, and other cannabis-based medications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Cannabis prescription consultation with optional video call |
| Unit Pricing | Pay-as-you-go | Medical cannabis flowers |
| Unit Pricing | Pay-as-you-go | Medical cannabis extracts and concentrates |
| Unit Pricing | Pay-as-you-go | Weight loss medication prescription |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
DrAnsay product offering
Product offeringCore offering
DrAnsay is a German telemedicine platform that issues online medical prescriptions for medical cannabis, weight loss medications, men's and women's health treatments, and general medicine through digital questionnaires and asynchronous physician review with optional video consultation. The platform integrates a pharmacy marketplace aggregating 350+ certified German pharmacies offering 1,400+ cannabis products with price comparison and best-price guarantee, with medications delivered or picked up at partner pharmacies within 1-4 business days.
Product overview
DrAnsay operates as a digital health platform providing telemedicine services for online medical prescriptions and treatments in Germany. The core offering consists of a platform connecting patients with licensed physicians for online consultations and partner pharmacies for medication fulfillment. The main service modules include: (1) Cannabis-Rezept for medical cannabis prescriptions, (2) Folgerezept for follow-up prescription renewals, (3) Abnehmspritze-Rezept for weight loss medications, (4) Allgemeinmedizin for general medicine and sick notes, (5) Frauengesundheit for women's health, and (6) Männergesundheit for men's health including erectile dysfunction. Supporting features include the DrAnsAI chatbot for 24/7 automated health support, a free Mental Health E-Book, and a mobile app. The platform aggregates 350+ pharmacies through a marketplace model offering 1,400+ cannabis products with best-price guarantees. Patients complete an online medical questionnaire, optionally participate in video consultations, receive digital prescriptions, and have medications shipped or picked up at partner pharmacies.
Differentiator
Problem solved
Functional benefit
Products and services
- Cannabis-Rezept (Medical Cannabis Prescription) Online medical cannabis prescription service enabling patients in Germany to obtain prescriptions for medical cannabis flowers, extracts, and other cannabis-based medications through a digital questionnaire and optional video consultation with licensed physicians, with fulfillment via the integrated pharmacy marketplace.
- Folgerezept (Follow-up Prescription) Free follow-up prescription service enabling patients to renew their existing prescriptions online without in-person doctor visits, supporting ongoing treatments for cannabis, weight loss, and other medications.
- Abnehmspritze-Rezept (Weight Loss Injection Prescription) Online prescription service for weight loss medications (injection-based treatments) targeting appetite regulation receptors to promote faster satiety and calorie reduction, with fulfillment via Stadsapotheek BV partner pharmacy.
- Allgemeinmedizin (General Medicine) General medicine service including online sick notes (Arbeitsunfähigkeitsbescheinigung) and prescriptions for common health conditions through telemedicine consultations.
- Frauengesundheit (Women's Health) Specialized telemedicine service for women's health conditions including PMS/PMDS, endometriosis, and other female-specific health concerns with prescriptions and follow-up care.
- Männergesundheit (Men's Health) Men's health telemedicine service addressing conditions such as erectile dysfunction and hair loss, providing discreet online consultations and prescriptions.
- Erektile Dysfunktion (Erectile Dysfunction) Dedicated service for erectile dysfunction treatment, offering discreet online consultations and prescription medications delivered to patients.
- Cannabis Apotheken-Marktplatz (Pharmacy Marketplace) Marketplace connecting patients with 350+ certified German pharmacies offering 1,400+ cannabis products (flowers, extracts, inhalations, drinkables, edibles, capsules) with price comparison and best-price guarantee across 16 manufacturers.
- DrAnsay Mobile App Mobile application for iOS and Android providing access to online prescriptions, physician consultations, and cannabis product ordering on the DrAnsay platform.
Quantifiable outcome
- Prescription issuance within 5-90 minutes (TAGESSPIEGEL test showed 10-minute prescription at 20:30)
- +2 more outcomes
Companies that use DrAnsay
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles2 records
DrAnsay technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration14 records
AI capability3 records
Feature3 records
DrAnsay partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Stadsapotheek BVcoreNetherlands-based pharmacy dispensing weight loss medications (GLP-1 agonists) to DrAnsay patients starting April 2026. Located at Monseigneur Nolensplein 26, 5911 GE Venlo, Netherlands. Registered in Dutch commercial register under number 12052219.
- 350+ German PharmaciescoreNetwork of over 350 certified pharmacies across Germany participating in DrAnsay's marketplace, offering medical cannabis products and fulfilling prescriptions. Includes 25+ pharmacies in Berlin and 350+ shipping pharmacies.
Scale indicators8 records
Recent moves5 records
Expansion highlights6 records
DrAnsay competitors and assessment
Company assessmentDirect peers
- DoktorABC: Germany-focused online clinic offering private prescriptions and online consultations across men's health, weight loss, and general conditions. Closest broad-telemedicine comparable for DrAnsay's non-cannabis verticals (ED, weight loss, general medicine).
- Bloomwell (formerly Algea Care): German cannabis e-commerce and prescription marketplace aggregating pharmacies and offering online cannabis prescribing. Directly comparable two-sided marketplace model with overlapping pharmacy network and DTC patient acquisition approach.
- Grünhorn Apotheken: German cannabis-specialist pharmacy chain that also operates its own patient-facing prescribing and fulfillment services. Represents both an indirect competitor (its own telehealth arm) and a partner-like entity with overlapping patient-flow economics in medical cannabis.
- cannamed: German direct-to-consumer cannabis telemedicine platform offering online cannabis prescriptions and pharmacy fulfillment. Closest direct competitor to DrAnsay, with overlapping patient segments, prescribing workflow, and German pharmacy marketplace model.
- Sanity Group: Berlin-based cannabis platform spanning cultivation, distribution, and patient services including telemedicine. Operates a comparable integrated cannabis-care model with pharmacy and digital prescription components that overlap with DrAnsay's offering.
- Kanna Medics: Specialized German cannabis telemedicine provider offering online evaluations, prescriptions, and pharmacy routing. Competes for the same chronic-pain, sleep-disorder, and qualifying-condition patients that form DrAnsay's primary cannabis segment.
Others
- DEMECAN: German medical-cannabis producer with wholesale distribution plus digital patient services. Existing DrAnsay content partner, but vertically integrated competitors producing domestically could plausibly bypass the marketplace and route patients directly to their own pharmacies.
- Shop Apotheke (RedCare Pharmacy): Public European online pharmacy retailer for OTC and pharmacy products in Germany and beyond. An adjacent e-commerce channel whose product breadth and logistics scale could pressure margins on the pharmacy marketplace layer if it expands into Rx fulfillment.
Broad incumbents
- Zava: Pan-European online doctor and e-prescription provider operating in Germany, the UK, France, and Ireland. Comparable telehealth and online-prescription model with overlapping verticals (ED, weight loss, women's health) but a much wider geographic footprint.
- TeleClinic (Medgate Deutschland): One of the largest general telemedicine providers in Germany offering video consultations, e-prescriptions, and sick notes across many specialties. A broader incumbent whose scale and insurance partnerships represent a competitive ceiling on DrAnsay's adjacent verticals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks1 record
Key highlights7 records
Customer concentration
DrAnsay social profiles
Digital presenceDrAnsay compliance and trust
Trust signalCompliance2 records
DrAnsay financial estimates
Financial estimateRevenue estimate
Valuation estimate
DrAnsay leadership team
Management profileNumber of profiles
Profiles1 record
DrAnsay funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DrAnsay M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DrAnsay
What does DrAnsay do?
DrAnsay is a German telemedicine platform that issues online medical prescriptions for medical cannabis, weight loss medications, men's and women's health treatments, and general medicine through digital questionnaires and asynchronous physician review with optional video consultation. The platform integrates a pharmacy marketplace aggregating 350+ certified German pharmacies offering 1,400+ cannabis products with price comparison and best-price guarantee, with medications delivered or picked up at partner pharmacies within 1-4 business days.
Is DrAnsay a public or private company?
DrAnsay is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was DrAnsay founded?
DrAnsay was founded in 2018. It employs 11 to 50 people.
Where is DrAnsay based?
DrAnsay is headquartered in Valletta, Malta, in the Europe region.
How does DrAnsay make money?
Three revenue lines are on record. Medical Consultation Fees are the primary driver. The others are pharmacy Marketplace Commission and cannabis Product Sales.
Who are DrAnsay's main competitors?
Direct peers on record are DoktorABC, Bloomwell (formerly Algea Care), Grünhorn Apotheken, cannamed, Sanity Group and Kanna Medics. Others are DEMECAN and Shop Apotheke (RedCare Pharmacy). Broad incumbents are Zava and TeleClinic (Medgate Deutschland).
Does DrAnsay have an API?
No public API is recorded for DrAnsay.
What industry is DrAnsay in?
DrAnsay's product category is Telemedicine / Online Healthcare Services. Its primary akta.pro industry code is HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription), with a secondary code of CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services). Its NAICS code is 62111 and its SIC code is 8000.